Tenon Medical, Inc. (TNON): who owns it and who trades it
As of Nov 16, 2026, TNON insiders reported 9 open-market sales worth $606K and 9 purchases worth $500K in the last 12 months, with 0% of the sale value made under pre-set 10b5-1 plans. The largest seller was Hrt Financial Lp (10% owner), with $606K. 1 of the 50 famous funds we follow held it at their last quarter end.
Latest filing Nov 16, 2026. From Form 4, 13F and Schedule 13D/G filings.
At a glance
Who is buying and selling Tenon Medical
From the latest filingsOverall: more selling than buying. Famous investors mostly sold. Insiders was close to even.
Each group counts equally in the meter, by the number of buyers and sellers, not dollars. Insider sales under pre-set 10b5-1 plans are left out of it. From SEC, House and Senate filings; not advice.
Insider trades
In the last 12 months, TNON insiders reported $500K of open-market purchases and $606K of sales. 0% of the sale value was under a 10b5-1 plan, a schedule set up in advance.
Purchases and sales by month
Latest trades
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Sep 10, 2026 | Hrt Financial Lp | 10% owner | Sale | 65,582 | $5.56 | $365K | Form 4 |
| Sep 10, 2026 | Hrt Financial Lp | 10% owner | Purchase | 8,431 | $4.92 | $41.5K | Form 4 |
| Sep 10, 2026 | Hrt Financial Lp | 10% owner | Purchase | 28,267 | $4.02 | $114K | Form 4 |
| Sep 10, 2026 | Hrt Financial Lp | 10% owner | Purchase | 31,227 | $2.92 | $91.2K | Form 4 |
| Sep 9, 2026 | Hrt Financial Lp | 10% owner | Sale | 50,395 | $2.61 | $132K | Form 4 |
| Sep 9, 2026 | Hrt Financial Lp | 10% owner | Purchase | 39,508 | $3.40 | $134K | Form 4 |
| Sep 9, 2026 | Hrt Financial Lp | 10% owner | Sale | 9,948 | $4.27 | $42.5K | Form 4 |
| Sep 8, 2026 | Hrt Financial Lp | 10% owner | Purchase | 707 | $3.34 | $2.4K | Form 4 |
| Sep 4, 2026 | Hrt Financial Lp | 10% owner | Sale | 1,506 | $3.70 | $5.6K | Form 4 |
| Sep 3, 2026 | Hrt Financial Lp | 10% owner | Purchase | 1,658 | $3.98 | $6.6K | Form 4 |
| Sep 2, 2026 | Hrt Financial Lp | 10% owner | Sale | 450 | $4.53 | $2K | Form 4 |
| Sep 1, 2026 | Hrt Financial Lp | 10% owner | Purchase | 1,790 | $4.57 | $8.2K | Form 4 |
| Aug 31, 2026 | Hrt Financial Lp | 10% owner | Sale | 1,276 | $4.66 | $5.9K | Form 4 |
| Aug 28, 2026 | Hrt Financial Lp | 10% owner | Purchase | 12,376 | $5.21 | $64.5K | Form 4 |
| Aug 28, 2026 | Hrt Financial Lp | 10% owner | Purchase | 5,981 | $6.35 | $38K | Form 4 |
| Aug 28, 2026 | Hrt Financial Lp | 10% owner | Sale | 4,932 | $7.07 | $34.9K | Form 4 |
| Aug 28, 2026 | Hrt Financial Lp | 10% owner | Sale | 2,091 | $7.90 | $16.5K | Form 4 |
| Aug 27, 2026 | Hrt Financial Lp | 10% owner | Sale | 419 | $4.96 | $2.1K | Form 4 |
Insiders by value traded
| Insider | Role | Bought | Sold | Last trade |
|---|---|---|---|---|
| Hrt Financial Lp | 10% owner | $500K | $606K | Sep 10, 2026 |
What this data shows, and what it doesn't
- Shows: open-market purchases and sales by officers, directors and 10%+ owners, reported on Form 4 within two business days of the trade.
- Leaves out: stock awards, option exercises, shares withheld for tax and gifts. These are not trades at a market price chosen by the insider.
- "plan" marks a sale made under a Rule 10b5-1 plan, a schedule set up in advance.
- Fund holders come from 13F reports, a snapshot at quarter end filed up to 45 days later.
- Filings are self-reported and can be amended. Each trade links to its original filing. Methodology
TNON short interest
High short interest. 14.2% of TNON shares are sold short: about 1 share in 7. Over the last 12 reports the number of shares short went down 46%.
As a rough guide, under 5% is low, 5–10% is moderate, 10–20% is high and over 20% is very high.
As of Oct 30, 2026, 94,671 TNON shares were sold short, 14.2% of the shares outstanding, up 82.8% from the report before. At the average daily volume of 152,023 shares, buying them all back would take about 1.0 trading days (days to cover).
Shares short, % of all shares
Days to cover
Every report
| Settlement date | Shares short | % of shares | Change | Avg daily volume | Days to cover |
|---|---|---|---|---|---|
| Oct 30, 2026 | 94,671 | 14.19% | +83% | 152,023 | 1.0 |
| Oct 15, 2026 | 51,800 | 7.77% | -15% | 895,424 | 1.0 |
| Sep 30, 2026 | 60,789 | 9.11% | -89% | 5.52M | 1.0 |
| Sep 15, 2026 | 539,306 | 80.85% | +315% | 25.97M | 1.0 |
| Aug 31, 2026 | 130,094 | 19.50% | +1518% | 6.36M | 1.0 |
| Aug 14, 2026 | 8,042 | 1.21% | -96% | 112,734 | 1.0 |
| Jul 31, 2026 | 223,450 | 1.98% | -54% | 384,853 | 1.0 |
| Jul 15, 2026 | 481,214 | 4.26% | -80% | 8.36M | 1.0 |
| Jun 30, 2026 | 2.38M | 21.03% | +826% | 34.58M | 1.0 |
| Jun 15, 2026 | 256,462 | 2.27% | +72% | 100,836 | 2.5 |
| May 29, 2026 | 149,174 | 1.32% | -16% | 51,387 | 2.9 |
| May 15, 2026 | 176,641 | 1.56% | -9% | 101,048 | 1.8 |
Short sellers borrow shares and sell them, hoping to buy them back for less. A high number means many such bets are open. It does not say where the price will go. Source: FINRA equity short interest, reported by brokers twice a month (positions on the 15th and the last business day) and published about 7 business days later. % of shares uses the share count on the company's latest SEC filing. What short interest means · Most shorted stocks
Tenon Medical company events
Tenon Medical filed 21 reports on Form 8-K in the last 12 months, 3 of them about an important change (leadership, listing). The latest was on Oct 22, 2026.
- Oct 22, 2026AgreementAs previously disclosed, on August 27, 2026, Tenon Medical, Inc., a Delaware corporation, entered into a securities purchase agreement with a certain institutional investor. Filing
- Sep 16, 2026AgreementTenon Medical, Inc. entered into an inducement offer letter agreement with a certain holder of outstanding Series A Common Stock Purchase Warrants exercisable for up to 572,179 shares of the Company’s common stock, par value $0.001 per share, which Existing Warrants were issued by the Company on… Filing
- Sep 9, 2026AnnouncementTenon Medical, Inc., a Delaware corporation, issued a press release announcing that it repaid in full its outstanding original issue discount senior convertible promissory notes, which were issued with an aggregate principal balance of approximately $5.16 million, ahead of their September 11, 2026… Filing
- Aug 31, 2026AgreementTenon Medical, Inc. entered into a securities purchase agreement with an institutional investor for the issuance and sale in a private placement of (i) pre-funded warrants to purchase up to an aggregate of 597,610 shares of the Company’s common stock, par value $0.001 per share, at a purchase price… Filing
- Aug 26, 2026AgreementAmended an earlier report. Tenon Medical, Inc., a Delaware corporation, entered into securities purchase agreements with certain accredited investors pursuant to which the Company agreed to issue and sell in a private placement an of $5.16 million 20% Original Issue Discount Senior Convertible Promissory Notes for aggregate… Filing
- Aug 24, 2026AnnouncementTenon Medical, Inc., a Delaware corporation, issued a press release announcing that on August 24, 2026 the Company received written notification from the Listing Qualifications staff of The Nasdaq Stock Market LLC confirming that the Company has regained compliance with the minimum bid price… Filing
- Aug 13, 2026ResultsReleased financial results. Filing
- Aug 10, 2026SharesChanged the rights of its shareholders. Filing
- Jul 24, 2026VoteReported shareholder vote results. Filing
- Jul 20, 2026AnnouncementWe issued a press release stating that on July 17, 2026, we received a notice from Nasdaq that based on the July 10 8-K (as defined below), we had regained compliance with the Stockholders’ Equity Rule (as defined below). Filing
- Jul 10, 2026AnnouncementTenon Medical, Inc., previously disclosed in a Current Report on Form 8-K that the Company received a notice dated May 21, 2026, from Nasdaq that the Company was no longer in compliance with the minimum stockholders’ equity requirement for continued listing on The Nasdaq Capital Market. Filing
- Jul 2, 2026AgreementTenon Medical, Inc., a Delaware corporation entered into securities purchase agreements with investors, pursuant to which on July 1, 2026, the Company consummated a best efforts public offering of an aggregate of (i) 5,526,315 shares of common stock, par value $0.001 per share and pre-funded… Filing
- Jun 12, 2026LeadershipOf this Current Report on Form 8-K is incorporated herein by reference. Filing
- Jun 11, 2026RulesChanged its bylaws or articles. Filing
- May 22, 2026ListingTenon Medical, Inc. received a written notice from The Nasdaq Stock Market LLC dated May 21, 2026, notifying the Company that it is no longer in compliance with the minimum stockholders’ equity requirement for continued listing on The Nasdaq Capital Market. Filing
- May 12, 2026ResultsReleased financial results. Filing
- Mar 19, 2026ResultsReleased financial results. Filing
- Mar 17, 2026AgreementTenon Medical, Inc., a Delaware corporation, entered into securities purchase agreements with certain accredited investors pursuant to which the Company agreed to issue and sell in a private placement an of $4.3 million 20% Original Issue Discount Senior Convertible Promissory Notes for aggregate… Filing
- Feb 27, 2026ListingTenon Medical, Inc. received a letter from the Nasdaq Listing Qualifications Staff of The Nasdaq Stock Market LLC therein stating that for the 30 consecutive business day period between January 9, 2026 and February 24, 2026, the common stock of the Company had not maintained a minimum closing bid… Filing
- Feb 6, 2026AnnouncementA copy of the press release referenced in Item 2.02 of this Current Report on Form 8-K is as Exhibit 99.1 to this Current Report on Form 8-K. The disclosure under Item 8.01, including Exhibit 99.1 hereto, is being furnished and shall not be deemed “filed” for purposes of Section 18 of the… Filing
- Nov 17, 2025AgreementTenon Medical, Inc., a Delaware corporation, entered into securities purchase agreements with certain accredited investors pursuant to which the Company agreed to issue and sell an aggregate of 2,217,904 shares of common stock, par value $0.001 per share, and/or pre-funded common stock purchase… Filing
From 8-K reports, which a company must file within 4 business days of an important event. Where a report is about a change such as a new CEO, the sentence is the first one from the report itself, shortened. Each row links to the original filing. Company events this week
Tenon Medical financials
Famous investors that hold TNON
1 of the 50 well-known investors we track reported holding TNON in their latest 13F filing. The largest position is Ken Griffin's, worth $201.
| Fund | Quarter | Shares | Value | Of portfolio | Change |
|---|---|---|---|---|---|
| Ken Griffin · Citadel Advisors | Q3 2026 | 33,574 | $201 | 0.0% | -52% |
From 13F reports: a snapshot at quarter end, filed up to 45 days later. Change compares with the quarter before.
Questions about Tenon Medical, Inc. (TNON) stock
Are TNON insiders buying or selling?
In the last 12 months, TNON insiders reported 9 open-market purchases worth $500K and 9 sales worth $606K. The latest trade was on Sep 10, 2026. See every trade.
What is the short interest in TNON?
As of Oct 30, 2026, 94,671 TNON shares were sold short, 14.2% of the shares outstanding, up 82.8% from the report before. At the average daily volume of 152,023 shares, buying them all back would take about 1.0 trading days (days to cover). See the history.
Which famous investors hold TNON?
1 of the 50 well-known investors we track reported TNON in their latest 13F filing, including Ken Griffin. The largest position is worth $201. See all holders.
Source: SEC Form 4 (insiders, filed within 2 business days), 13F (funds, up to 45 days after quarter end) and Schedule 13D/13G filings. Only open-market purchases (code P) and sales (code S) are shown. Data only, not investment advice. How we collect it.